Cognitive Neuroscience Laboratory, University of West Florida, Pensacola, FL, USA.
, Pensacola, USA.
Appl Psychophysiol Biofeedback. 2018 Jun;43(2):153-159. doi: 10.1007/s10484-018-9392-6.
The flash visual evoked potential P2 (FVEP-P2) has been identified as a potentially useful clinical, diagnostic tool for Alzheimer's dementia (AD) and mild cognitive impairment (MCIa) due to its association with cholinergic functioning in the brain. The FVEP-P2 is the second positive component of the VEP waveform elicited by a single strobe flash. Despite finding a selective delay in the latency of the FVEP-P2 in AD and MCIa groups, adequate levels of sensitivity and specificity have not been achieved due to natural group differences and inter-individual variability. In response, Fix and colleagues introduced a novel, double-stimulation paradigm that contained two strobe flashes (i.e., stimulations). The first stimulation served as a visual challenge while the second stimulation produced the recorded FVEP-P2 component. The results of that investigation indicated that the latency of the FVEP-P2 could be used to reliably discriminate between aMCI and healthy controls when the ISI of the double-stimulation condition was 100 ms or higher. Unfortunately, very little is known regarding the psychometric properties of the FVEP-P2 when produced by a double-stimulation condition. Consequently, we assessed the test-retest reliability of the FVEP-P2 latency produced by a single- and twelve double-stimulation conditions in a sample of young, healthy individuals (N = 20). Results indicated that while the FVEP-P2 latencies produced by the single- and double-stimulation paradigm were reliable, the intra-individual variability continued to be too high for the FVEP-P2 latency to be used clinically. Methods of reducing the intra-individual variability are discussed, including the use of monochromatic light.
闪光视觉诱发电位 P2(FVEP-P2)已被确定为一种潜在有用的临床诊断工具,可用于阿尔茨海默病(AD)和轻度认知障碍(MCIa),因为它与大脑中的胆碱能功能有关。FVEP-P2 是由单个闪光刺激引起的 VEP 波形的第二个正成分。尽管在 AD 和 MCIa 组中发现 FVEP-P2 的潜伏期存在选择性延迟,但由于自然组间差异和个体间变异性,尚未达到足够的灵敏度和特异性。作为回应,Fix 及其同事引入了一种新的双刺激范式,其中包含两个闪光刺激(即刺激)。第一个刺激作为视觉挑战,而第二个刺激产生记录的 FVEP-P2 成分。该研究的结果表明,当双刺激条件的 ISI 为 100ms 或更高时,FVEP-P2 的潜伏期可用于可靠地区分 aMCI 和健康对照者。不幸的是,对于双刺激条件下产生的 FVEP-P2 的心理测量特性知之甚少。因此,我们在一组年轻健康个体(N=20)中评估了单刺激和 12 种双刺激条件下 FVEP-P2 潜伏期的测试-重测信度。结果表明,虽然单刺激和双刺激范式产生的 FVEP-P2 潜伏期是可靠的,但个体内变异性仍然过高,无法在临床上使用 FVEP-P2 潜伏期。讨论了降低个体内变异性的方法,包括使用单色光。